Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production

P. M. Schlievert, J. A. Kelly

Research output: Contribution to journalArticlepeer-review

124 Scopus citations


Clindamycin is a derivative of lincomycin, which is generally regarded to inhibit protein synthesis after binding to the 50S subunit of bacterial ribosomes. The antibiotic also has the capacity to suppress expression of certain bacterial exotoxins, such as exfoliative toxin and streptolysin O and S, by an as-yet-undefined mechanism. In the present study the effect of clindamycin (provided by J. Sanford, Upjohn Co, Kalamazoo, Mich) on various TSS isolates of S aureus was evaluated. These isolates are consistently resistant to penicillin and ampicillin but are considered sensitive to many other antibiotics.

Original languageEnglish (US)
Number of pages1
JournalJournal of Infectious Diseases
Issue number3
StatePublished - Jan 1 1984


Dive into the research topics of 'Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production'. Together they form a unique fingerprint.

Cite this